Pure Global
NCT06321367

Model to Predict Coinfection in Elderly Patients With COVID-19

Construction and Validation of a Predictive Model of Coinfections in Elderly COVID-19 Patients After Abandoning Zero Policy
Xiangya Hospital of Central South University·ClinicalTrials.govCompleted
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Covid19
Study type
Observational
Sponsor & location
Primary sponsor
Xiangya Hospital of Central South University
Location
Changsha, China
Timeline & enrollment
Phase
N/A
Start date
Dec 20, 2022
End date
Jun 30, 2023
Enrollment
1000 participants
Primary outcome

Coinfection

Summary

The goal of this observational study is to learn about the clinical characteristics and
 construction of a predictive model in elderly COVID-19 patients. The main question it aims to
 answer is the main clinical characteristics and risk factors of elderly COVID-19 patients.
 Participants will not be asked to do any other intervening measure.

ICD-10 classifications
COVID-19, virus identifiedCOVID-19, virus not identifiedCoronavirus infection, unspecified siteRift Valley feverPlague
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06321367
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06321367 through Pure Global AI's free database. This phase not specified trial is sponsored by Xiangya Hospital of Central South University and is currently Completed. The study focuses on Covid19. Target enrollment is 1000 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.